Intuitive Surgical INC 10-Q quarterly reports

Intuitive Surgical announces robust revenue and procedure growth in its Q2 2026 results, driven by strong demand for its da Vinci systems and instruments.

Intuitive Surgical reported strong Q1 2026 growth with revenue rising 23% to $2.77 billion, driven by increased da Vinci and Ion procedure volumes.

Intuitive Surgical's Q3 revenue increased 23% year-over-year, driven by procedure growth and system placements.

Intuitive Surgical, Inc. announced robust revenue and procedure growth for the second quarter of 2025, driven by increased system placements and procedure volumes, though gross profit margins faced pressure from new product launches and tariffs.

Intuitive Surgical's Q1 2025 results show a significant increase in revenue driven by procedure growth and system placements, despite facing potential tariff headwinds.

Intuitive Surgical's Q3 2024 results show significant revenue growth driven by increased procedure volumes and system placements, particularly for the da Vinci and Ion systems.

Intuitive Surgical's Q2 2024 results show a 14% revenue increase, driven by growth in da Vinci procedures and system placements, alongside advancements in their product ecosystem.

Intuitive Surgical's first quarter of 2024 saw an 11% increase in revenue, fueled by growth in da Vinci and Ion procedures and the introduction of the da Vinci 5 system.